19 年
手机商铺
公司新闻/正文
318 人阅读发布时间:2023-02-06 15:33
一 产品介绍
TGF-β 是一种多功能细胞因子,可调节上皮细胞增殖细胞、内皮细胞、成纤维细胞、神经元、淋巴样细胞(包括 T 淋巴细胞和 NK 细胞)以及其他造血细胞类型。TGF-β 还调节活化巨噬细胞的活性和调节性 T 细胞的发育。此外,TGF-β 在免疫功能、组织重塑和伤口修复中发挥作用。TGF-β 以五种高度相似的亚型 (TGF-β 1-5) 存在,同源性为 70-80%。TGF-β1 是通过酶切由 TGFB1 基因编码的长前体 TGF-β1 多肽合成的,该基因产生成熟蛋白和潜伏相关肽 (LAP)。LAP 和成熟的 TGF-β1 在分泌过程中非共价结合。TGF-β 由许多细胞类型普遍表达,包括表达高水平 TGF-β 的巨噬细胞和血小板。TGF-β 信号已被证明在癌症、自身免疫性疾病、哮喘、心脏病和糖尿病中发挥作用。TGF-β 基因敲除小鼠显示出造血功能和内皮细胞分化缺陷,并死于压倒性炎症,说明了其重要性。1D11.16.8单克隆抗体是一种中和抗体。TGF-β 基因敲除小鼠显示出造血功能和内皮细胞分化缺陷,并死于压倒性炎症,说明了其重要性。1D11.16.8单克隆抗体是一种中和抗体。TGF-β 基因敲除小鼠显示出造血功能和内皮细胞分化缺陷,并死于压倒性炎症,说明了其重要性。1D11.16.8单克隆抗体是一种中和抗体。

二 产品详情
| 产品详情 | |
| 产品编号 | BE0057 |
| 同型 | Mouse IgG1,κ |
| 推荐的同种型对照 | InVivo MAb mouse IgG1 同种型对照 |
| 推荐的稀释缓冲液 | InVivo Pure pH 7.0 稀释缓冲液 |
| 免疫原 | Bow TGFβ 2 |
| 产品应用用途 | 体内TGFβ 中和、体外TGFβ 中和Western blot |
| 产品组分 | PBS,pH 7.0不含稳定剂或防腐剂 |
| 内毒素 | <2EU/mg (<0.002EU/μg)通过 LAL 试验测定 |
| 纯度 | >95%由 SDS-PAGE 确定 |
| 无菌性 | 0.2 μM 过滤 |
| 生产 | 在无动物设施中从组织培养上清液中纯化 |
| 纯化 | Protein G |
| RRID | AB_1107757 |
| 分子量 | 150 kDa |
| 贮存 | 抗体溶液应在 4°C 下以原液浓度储存 |
三 已发表文献
| 用途 | 已发表文献 |
| in vivo TGFβ neutralization | Komai, T., et al. (2018). "Transforming Growth Factor-beta and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals" Front Immunol 9: 1364 |
| in vivo TGFβ neutralization | Clemente-Casares, X., et al. (2016). "Expanding antigen-specific regulatory networks to treat autoimmunity" Nature 530(7591): 434-440 |
| in vivo TGFβ neutralization | Manlove, L. S., et al. (2015). "Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells" J Immunol |
| in vivo TGFβ neutralization | Bodogai, M., et al. (2015). "Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells" Cancer Res 75(17): 3456-3465. |
| in vivo TGFβ neutralization | Choi, Y. S., et al. (2015). "LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6" Nat Immunol 16(9): 980-990 |
| in vivo TGFβ neutralization | Greco, S. H., et al. (2015). "TGF-beta Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia" PLoS One 10(7): e0132786 |
| in vivo TGFβ neutralization | Leon, B., et al. (2014). "FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability" Nat Commun 5: 3495. |
| in vivo TGFβ neutralization | Li, W., et al. (2014). "Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis" J Clin Invest 124(2): 755-767 |
| in vivo TGFβ neutralization | Worthington, J. J., et al. (2013). "Loss of the TGFbeta-activating integrin alphavbeta8 on dendritic cells protects mice from chronic intestinal parasitic infection via control of type 2 immunity" PLoS Pathog 9(10): e1003675 |
| in vivo TGFβ neutralization | Ring, S., et al. (2013). "Targeting of autoantigens to DEC205(+) dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice" J Immunol 191(6): 2938-2947 |
| in vivo TGFβ neutralization | Tai, N., et al. (2013). "TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice" J Immunol 191(6): 2926-2937 |
| in vivo TGFβ neutralization | Kurkjian, C., et al. (2012). "Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection" Infect Immun 80(8): 2835-2846. |
| in vivo TGFβ neutralization | Garidou, L., et al. (2012). "Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection" J Virol 86(13): 7060-7071 |
详情请咨询 BioXcell 中国授权代理-优宁维生物
上海优宁维生物科技股份有限公司
试剂 | 耗材 | 仪器 | 软件 | 定制 | 实验服务 | 供应链
免费热线:4008-168-068
咨询邮箱:info@univ-bio.com
订购商城:www.univ-bio.com
微信公众平台:优宁维抗体专家,欢迎关注!
小优博士(小程序):5大课堂, 让你的科研不再难!